C Frank Bennett Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 3 hours ago
C Frank Bennett has an estimated net worth of at least $20.6 million*, as of March 11, 2026. They own 80,554 shares of IONS stock. They have sold 315,102 shares of IONS stock since 2021, for an estimated $14.5 million.
C Frank Bennett $IONS SEC Form 4 Insider Trading
C Frank Bennett has filed a total of 23 insider trades in $IONS since 2021. Their most recent trade was a sale of 802 shares, made on Mar 03, 2026. Their largest trade was a sale of 71,600 shares, made on Mar 03, 2026. We estimate that they now own 80,554 shares of $IONS, worth an estimated $6.1 million.
Insider Trading at $IONS
There have been a total of 278 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 2.8 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Eric Swayze, and Patrick R. O'Neil. The most recent trade was a sale of 832 shares reported by JOSEPH LOSCALZO (None), made on Mar 03, 2026.
History of Insider Stock Trades by C Frank Bennett
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IONS
|
Sale | 802 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
IONS
|
Sale | 71,600 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
IONS
|
Sale | 12,687 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
IONS
|
Sale | 48,626 | Feb 02, 2026 | Feb. 4, 2026, 5:06 p.m. |
IONS
|
Sale | 16,463 | Feb 02, 2026 | Feb. 4, 2026, 5:06 p.m. |
IONS
|
Sale | 20,000 | Feb 02, 2026 | Feb. 4, 2026, 5:06 p.m. |
IONS
|
Sale | 5,885 | Jan 30, 2026 | Feb. 2, 2026, 9:51 p.m. |
IONS
|
Sale | 8,977 | Jan 16, 2026 | Jan. 20, 2026, 9:18 p.m. |
IONS
|
Sale | 6,000 | Sep 05, 2025 | Sept. 9, 2025, 6:30 p.m. |
IONS
|
Sale | 5,000 | Sep 02, 2025 | Sept. 4, 2025, 8:29 p.m. |
IONS
|
Sale | 33,909 | Sep 03, 2025 | Sept. 4, 2025, 8:29 p.m. |
IONS
|
Sale | 10,000 | Aug 18, 2025 | Aug. 20, 2025, 6:14 p.m. |
IONS
|
Sale | 1,327 | Jan 31, 2025 | Feb. 3, 2025, 8:26 p.m. |
IONS
|
Sale | 6,752 | Jan 16, 2025 | Jan. 17, 2025, 8:40 p.m. |
IONS
|
Sale | 1,853 | Feb 02, 2024 | Feb. 2, 2024, 8:54 p.m. |
IONS
|
Sale | 6,745 | Jan 17, 2024 | Jan. 18, 2024, 6:44 p.m. |
IONS
|
Sale | 16,113 | Dec 21, 2023 | Dec. 22, 2023, 8:11 p.m. |
IONS
|
Sale | 6,500 | Dec 20, 2023 | Dec. 22, 2023, 8:11 p.m. |
IONS
|
Sale | 8,610 | Dec 14, 2023 | Dec. 18, 2023, 5:55 p.m. |
IONS
|
Sale | 14,002 | Dec 14, 2023 | Dec. 18, 2023, 5:55 p.m. |
IONS
|
Sale | 4,460 | Sep 28, 2023 | Sept. 29, 2023, 5:20 p.m. |
IONS
|
Sale | 1,813 | Feb 06, 2023 | Feb. 7, 2023, 6:36 p.m. |
IONS
|
Sale | 6,978 | Jan 18, 2023 | Jan. 19, 2023, 9:19 p.m. |
$IONS Executives and Stock Owners with Insider Trades
-
Brett P Monia, Chief Executive Officer
-
Eric Swayze, EVP Research
-
Patrick R. O'Neil, EVP CLO & General Counsel
-
Richard S Geary, EVP, Chief Development Officer
-
C Frank Bennett, EVP, Chief Scientific Officer
-
Joseph Baroldi, EVP, Chief Business Officer
-
Shannon L. Devers, EVP, Chief Human Resources Ofc
-
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
-
Brian Birchler, EVP, Corp and Development Ops
-
Elizabeth L Hougen, EVP, Finance & CFO
-
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
-
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr
-
Holly B. Kordasiewicz, EVP, Chief Development Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.